OSU K12 Training Grant in Oncology

OSU K12 肿瘤学培训补助金

• 批准号: 10224104
• 负责人: WILLIAM E. CARSON
• 金额: $ 79.74万
• 依托单位: OHIO STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-09-09 至 2024-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10224104
• 关键词: Applied Research; Area; Basic Science; Clinical; Clinical Investigator; Clinical Research; Clinical Trials; Comprehensive Cancer Center; Discipline; Doctor of Philosophy; Ensure; Faculty; Financial Support; Goals; Grant; Hematology; Individual; Investigation; Investigational Therapies; Laboratories; Malignant Neoplasms; Medical Oncology; Medicine; Mentored Clinical Scientist Development Program; Mentors; Minority Groups; Ohio; Oncology; Paper; Peer Review; Program Evaluation; Radiation Oncology; Research; Research Personnel; Resources; SECTM1 gene; Structure; Surgical Oncology; Training; Training Programs; Underserved Population; Universities; Women' s Group; anticancer research; base; cancer diagnosis; cancer prevention; career; career development; drug development; education research; effectiveness evaluation; interest; laboratory development; programs; recruit; success; survivorship; translational cancer research; translational scientist

Project Summary/Abstract The goal of this proposal is to mentor and train junior faculty investigators in laboratory and/or clinical translational cancer research. Implementation of this K12 program for the career development of laboratory-based (PhD/DVM/MD) and clinical (MD or MD/PhD) translational scientists in diverse areas of oncology will ensure a cadre of highly-trained individuals who can communicate across disciplines to drive new advancements in how we approach cancer diagnosis and management. This K12 program from The Ohio State University Comprehensive Cancer Center (OSUCCC) continues its focus on early drug development, but now also extends to cancer prevention, control and survivorship research. The OSUCCC is clearly dedicated to research education and providing outstanding career development and mentoring opportunities to promising junior faculty. The Divisions of Hematology, Medical Oncology, Radiation Oncology, and Surgical Oncology each have robust programs that are continuously recruiting new junior faculty to facilitate expansion of our cancer program. Recruitment efforts also emphasize the inclusion of women, minorities and underserved groups to increase diversity. This K12 grant fills an important need by extending research education, career development and mentoring to junior faculty interested in establishing academic research careers. It is the only OSUCCC training program dedicated solely to faculty-level career development in cancer research, and thus has no overlap with any of the OSU T32 training grants, which focus on fellows. This strategy ensures continuity in training and provides individuals a structured path to become independent clinical or translational investigators. The quality of this K12 program and its success in training cancer researchers is exemplified by the career trajectories of past trainees, their papers, grants, clinical trials and other scholarly activities that have driven new discoveries. The continued success of this program will be ensured by the overall strength and direction of the OSUCCC, as demonstrated by its recent peer review score of 10 (exceptional), financial support of this K12 program by the OSUCCC and by different Divisions and Departments, and the enormous breadth of expertise and resources available at OSU. This K12 program seeks to train two types of investigators. The first includes MD and/or PhD faculty who have outstanding basic science training and want to pursue laboratory-based investigation related to applied research in experimental therapeutics, cancer prevention, control, and survivorship. The second group includes MD or MD/PhD faculty who want to pursue clinical research in experimental therapeutics and cancer prevention, control, or survivorship. Training plans are tailored to each individual trainee to facilitate their success, with inclusion of a robust evaluation program to assess the effectiveness of the K12. The value of the OSU K12 program is best demonstrated by nearly all of the current and past K12 scholars remaining in academic medicine and moving forward as independent laboratory or clinical investigators.

项目摘要/摘要 该建议的目的是指导和培训实验室和/或临床翻译的初级教师研究人员 癌症研究。实施此K12计划，用于实验室的职业发展 （博士/DVM/MD）和临床（MD或MD/PHD）肿瘤学领域的转化科学家将确保 训练有素的人的干部可以跨学科进行交流，以推动新的进步 我们处理癌症的诊断和管理。俄亥俄州立大学的K12计划 综合癌症中心（OSUCCC）继续关注早期药物开发，但现在也扩展了 预防癌症，控制和生存研究。 OSUCCC显然致力于研究教育 并为有前途的初级教师提供杰出的职业发展和指导机会。这 血液学，医学肿瘤学，辐射肿瘤学和外科肿瘤学的分裂均具有强大的 不断招募新的初级教师以促进我们的癌症计划的计划。 招聘工作还强调妇女，少数民族和服务不足的群体的加入以增加 多样性。通过扩展研究教育，职业发展和 对有兴趣建立学术研究职业的初级教师的指导。这是唯一的OSUCCC培训 专门用于癌症研究中教师职业发展的计划，因此与 OSU T32培训补助金的任何一项，侧重于研究员。该策略可确保培训的连续性和 为个人提供成为独立临床或转化研究者的结构性途径。质量 在这个K12计划及其在培训癌症研究人员方面的成功，体现了 过去的学员，他们的论文，赠款，临床试验和其他引起新发现的学术活动。 该计划的持续成功将通过OSUCCC的整体力量和方向来确保 以其最近的同行评审得分为10（例外）证明，该计划的财政支持 OSUCCC以及不同的部门和部门以及巨大的专业知识和资源广度 可在OSU上找到。该K12计划旨在培训两种类型的调查人员。第一个包括MD和/或博士学位 拥有杰出的基础科学培训并希望与实验室调查有关的教师 用于应用实验治疗，预防癌症，控制和生存方面的研究。第二组 包括想从事实验治疗和癌症临床研究的MD或MD/PHD教师 预防，控制或生存。培训计划是针对每个学员量身定制的，以促进他们的 成功，包括一个可靠的评估计划来评估K12的有效性。价值 OSU K12计划最好由几乎所有当前和过去的K12学者证明 医学和作为独立实验室或临床研究人员的前进。